Back to Search

RCUS

Arcus Biosciences, Inc.
Data: 2026-01-30
$21.04
Price
-3.30%
Change
$26.4
52W High
$6.5
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Quick Stats
Jan 30, 2026

56.8

AI Score

HOLD

1.02

Volume Ratio

Feb 24, 2026

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

RCUS Stock Summary

Last updated Jan 30, 2026

RCUS is currently trading at $21.04, positioned above its 200-day moving average of $14.35, indicating a long-term uptrend. The stock has a 52-week range of $6.5 to $26.4.

Technical Analysis: The 50-day moving average stands at $23.02, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.325, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.128, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RCUS at 56.8/100 with a HOLD recommendation.

RCUS (Arcus Biosciences, Inc.) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 43.325
CMF (20) 0.128
ROC (10) -3.442
ADX (14) 11.72
Indicator Value
MACD (12,26,9) -0.211
AROONOSC (14) 28.571
WILLAMS %R (14) -89.873
MFI (14) 53.145
RCUS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RCUS Price vs Max Options Open Interest
RCUS Max Change In Options Open Interest

RCUS Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RCUS Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RCUS Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RCUS Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Arcus Biosciences, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

RCUS Moving Averages Analysis

Arcus Biosciences, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026

RCUS (Arcus Biosciences, Inc.) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 22.19
20 22.23
30 22.45
50 23.02
100 19.46
200 14.35

RCUS Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 2.7 billion
Earnings/Share ($) -3.42
Net Proft Margin (%) -1.4208
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.5
EPS Estimate Next Year ($) -3.8525
WallStreet Target Price ($) 33
Most Recent Quarter